Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Steven J. Charlton"'
Autor:
David A. Sykes, Mireia Jiménez‐Rosés, John Reilly, Robin A. Fairhurst, Steven J. Charlton, Dmitry B. Veprintsev
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 4, Pp n/a-n/a (2022)
Abstract In this study, we report the β1‐adrenoceptor binding kinetics of several clinically relevant β1/2‐adrenoceptor (β1/2AR) agonists and antagonists. [3H]‐DHA was used to label CHO‐β1AR for binding studies. The kinetics of ligand bin
Externí odkaz:
https://doaj.org/article/23a0dbaf85364a89ad9273ace3affdf9
Autor:
Maxine J. Roberts, Lauren T. May, Alastair C. Keen, Bonan Liu, Terrance Lam, Steven J. Charlton, Elizabeth M. Rosethorne, Michelle L. Halls
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Idiopathic pulmonary fibrosis is a chronic and progressive fibrotic lung disease, and current treatments are limited by their side effects. Proliferation of human lung fibroblasts in the pulmonary interstitial tissue is a hallmark of this disease and
Externí odkaz:
https://doaj.org/article/5c85396c76d64dc79fc084910f1ff65a
Autor:
David A. Sykes, J. Robert Lane, Monika Szabo, Ben Capuano, Jonathan A. Javitch, Steven J. Charlton
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-5 (2018)
Externí odkaz:
https://doaj.org/article/3b5818ff24944d2888354db7faccd2e3
Autor:
Maxine J. Roberts, Rebecca E. Broome, Toby C. Kent, Steven J. Charlton, Elizabeth M. Rosethorne
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic lung disease for which there is no cure. Current therapeutics are only able to slow disease progression, therefore there is a need to explore alternative, n
Externí odkaz:
https://doaj.org/article/06e8bdf96a7a40f48b463226c6ba76c7
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Abstract Fundamental equations for determining pharmacological parameters, such as the binding affinity of a ligand for its target receptor, assume a homogeneous distribution of ligand, with concentrations in the immediate vicinity of the receptor be
Externí odkaz:
https://doaj.org/article/c6d4744a7ab4476ba13f01e717ce7624
Autor:
David A. Sykes, Holly Moore, Lisa Stott, Nicholas Holliday, Jonathan A. Javitch, J. Robert Lane, Steven J. Charlton
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Atypical antipsychotics show reduced extrapyramidal side effects compared to first generation drugs. Here the authors use time-resolved FRET to measure binding kinetics, and show that side effects correlate with drug association rates to the D2 recep
Externí odkaz:
https://doaj.org/article/92ce2e6b0c464f92849b40c8f8648e24
Autor:
Carmen Klein Herenbrink, David A. Sykes, Prashant Donthamsetti, Meritxell Canals, Thomas Coudrat, Jeremy Shonberg, Peter J. Scammells, Ben Capuano, Patrick M. Sexton, Steven J. Charlton, Jonathan A. Javitch, Arthur Christopoulos, J. Robert Lane
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Biased agonists act at a receptor to preferentially induce distinct intracellular signalling responses over others. Here the authors show how kinetics of ligand binding and signaling responses greatly influence observed bias profiles, and hence must
Externí odkaz:
https://doaj.org/article/0783ff6940594b04b8cd38d7c0762fb1
Autor:
Hsin-Yung Yen, Idlir Liko, Wanling Song, Parth Kapoor, Fernando Almeida, Joanna Toporowska, Karolina Gherbi, Jonathan T. S. Hopper, Steven J. Charlton, Argyris Politis, Mark S. P. Sansom, Ali Jazayeri, Carol V. Robinson
Publikováno v:
Nature Chemistry. 14:1375-1382
G-protein-coupled receptors signal through cognate G proteins. Despite the widespread importance of these receptors, their regulatory mechanisms for G-protein selectivity are not fully understood. Here we present a native mass spectrometry-based appr
Autor:
David A. Sykes, Mireia Jiménez‐Rosés, John Reilly, Robin A. Fairhurst, Steven J. Charlton, Dmitry B. Veprintsev
Publikováno v:
Pharmacology Research & Perspectives. 10
Autor:
Katy J. Sutcliffe, Robin A Corey, Norah Alhosan, Damiana Cavallo, Sam Groom, Marina Santiago, Chris Bailey, Steven J. Charlton, Richard B. Sessions, Graeme Henderson, Eamonn Kelly
Publikováno v:
Sutcliffe, K J, Corey, R A, Alhosan, N, Cavallo, D, Groom, S, Santiago, M, Bailey, C, Charlton, S J, Sessions, R B, Henderson, G & Kelly, E 2022, ' Interaction With the Lipid Membrane Influences Fentanyl Pharmacology ', Advances in drug and alcohol research, vol. 2, 10280 . https://doi.org/10.3389/adar.2022.10280
Overdose deaths from fentanyl have reached epidemic proportions in the USA and are increasing worldwide. Fentanyl is a potent opioid agonist that is less well reversed by naloxone than morphine. Due to fentanyl’s high lipophilicity and elongated st